Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn
2021-03-16
0:00
15:37
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.
Fler avsnitt från "MedEdTalks - Gastroenterology"
Missa inte ett avsnitt av “MedEdTalks - Gastroenterology” och prenumerera på det i GetPodcast-appen.